Last $5.26 USD
Change Today -0.06 / -1.13%
Volume 150.7K
ENZ On Other Exchanges
As of 8:04 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

527 Madison Avenue

New York, NY 10022

United States

Phone: 212-583-0100


Enzo Biochem, Inc. operates as a life sciences and biotechnology company. The company serves as a provider of test services, including esoteric tests, to the medical community. Segments The company operates in three segments: Enzo Clinical Labs, Enzo Life Sciences, and Enzo Therapeutics. The Enzo Clinical Labs segment is a regional clinical laboratory serving the New York, New Jersey and Eastern Pennsylvania medical communities. This segment offers a menu of routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. The company operates a full-service clinical laboratory in Farmingdale, New York, a network of approximately 35 patient service centers throughout New York and New Jersey, a stand-alone ‘stat’ or rapid response laboratory in New York City and a full-service phlebotomy, in-house logistics department, and information technology department. The Enzo Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development and clinical research customers world-wide. The company’s portfolio of proteins, antibodies, peptides, small molecules, labeling probes, dyes and kits provides life science researchers tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. The company manufactures, in-licenses, and commercializes approximately 7,500 of its own products and in addition distributes approximately 30,000 products made by 40 other original manufacturers. The segment is a source for a panel of products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity and renal injury. The Enzo Therapeutics segment is a biopharmaceutical venture that has developed multiple various approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases. This segment has focused its activities on developing treatment regimens for diseases and conditions for which treatment options are ineffective, and/or cause unwanted side effects. Products and Services The company applies its core technologies to develop novel therapeutics, as well as research tools for the life sciences and clinical diagnostics markets. In addition, the company provides clinical laboratory services to physicians and other health care providers in the New York, New Jersey and Eastern Pennsylvania medical communities. Research Products The company is engaged in the development, production, marketing and sales of life science research reagents worldwide, through two main channels to market: Enzo Life Sciences – ‘Scientists enabling Scientists’ Enzo Life Sciences is a positioned as a manufacturer and supplier of reagents, kits and products supplied to customers in Life Sciences Research, Clinical Research and Drug Development. With direct sales operations in U.S., Switzerland, Germany, U.K., France and Benelux, Enzo Life Sciences also supports its 7,000 products through a network of distributors. –‘The Reagents Marketplace’, Thousands of Reagents, One Marketplace is a distribution platform for original manufacturers of research reagents. The products supplied by Enzo Life Sciences include small molecules, proteins, antibodies, peptides, probes, assay kits and custom services. The company’s comprehensive portfolio of reagents and kits in various research areas are sold to scientific experts in the following fields: Adipokines, Antibiotics, Apotosis/Cell Death, Biologically Active Peptides, Bone Metabolism, Cancer Research, Cell Death, Cell Cycle, Chemokines/Cytokines, Cytoskeletal Research, Dependence Receptors, DNA Fragmentation/Damage/Repair, DNA Regulation, Epigenetics, FISH, Growth Factors/Cytokines, Hypoxia, Immunology, Viral Signaling, Inflammation/Innate Immunity, Interferons, In Vitro Toxicology, Kinases/Inhibitors, Leukotrienes/P


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENZ:US $5.26 USD -0.06

ENZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Affymetrix Inc $8.19 USD -0.08
Computer Programs & Systems Inc $57.97 USD -0.20
HealthStream Inc $25.01 USD -0.09
Luminex Corp $19.15 USD -0.06
Merge Healthcare Inc $2.32 USD -0.05
View Industry Companies

Industry Analysis


Industry Average

Valuation ENZ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book 6.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at